Persistence of SARS-Cov-2 Igg Antibody Response among South African Adults: A Prospective Cohort Study
Preprint
- 8 May 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
This study assesses the durability of severe acute respiratory coronavirus-2 (SARS-CoV-2) anti-nucleocapsid (anti-N) immunoglobulin G (IgG) after infection, and examines its association with established risk factors among South African healthcare workers (HCWs). Blood samples were obtained from 390 HCWs with diagnosis of coronavirus disease 2019 (COVID-19) for assay of the SARS-CoV-2 anti-N IgG at two time points (Phase 1 & 2) between November 2020 and February 2021. Out of 390 HCWs with COVID-19 diagnosis, 267 (68.5%) had detectable SARS-CoV-2 anti-N IgG antibodies at the end of phase I. These antibodies persisted for 4-5 and 6-7 months in 76.4% and 16.1%, respectively. In the multivariate logistic regression model analysis, black participants were more likely to sustain SARS-CoV-2 anti-N IgG for 4-5 months. However, participants who were HIV positive were less likely to sustain SARS-CoV-2 anti-N IgG antibodies for 4-5 months. In addition, individuals who were <45 years of age were more likely to sustain SARS-CoV-2 anti-N IgG for 6-7 months. Of the 202 HCWs selected for phase 2, 116 participants (57.4%) had persistent SARS-CoV-2 anti-N IgG for an extended mean period of 223 days (7.5 months). Findings support the longevity of vaccine responses against SARS CoV-2 in black Africans.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational studyThe Lancet HIV, 2021
- SARS-CoV-2 immunity and HIV infection: total recall?The Lancet HIV, 2021
- SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacyeClinicalMedicine, 2021
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)The Lancet, 2021
- Risk of COVID-19 in health-care workers in Denmark: an observational cohort studyThe Lancet Infectious Diseases, 2020
- Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort studyDiabetologia, 2020
- Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort studyThe Lancet Public Health, 2020
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and AntigenicityCell, 2020
- How the pandemic might play out in 2021 and beyondNature, 2020
- Understanding Antibody Testing for COVID-19The Journal of Arthroplasty, 2020